HMGCR

Summary

Gene Symbol: HMGCR
Description: 3-hydroxy-3-methylglutaryl-CoA reductase
Alias: LDLCQ3, 3-hydroxy-3-methylglutaryl CoA reductase (NADPH), 3-hydroxy-3-methylglutaryl-Coenzyme A reductase, HMG-CoA reductase, hydroxymethylglutaryl-CoA reductase
Species: human

Top Publications

  1. ncbi Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension
    Parshuram J Sonawane
    Cardiovascular Genetics Laboratory, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India
    PLoS ONE 6:e16661. 2011
  2. ncbi Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain
    Navdar Sever
    Department of Molecular Genetics, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
    Mol Cell 11:25-33. 2003
  3. ncbi Polymorphisms associated with cholesterol and risk of cardiovascular events
    Sekar Kathiresan
    Cardiovascular Disease Prevention Center, Cardiology Division, Massachusetts General Hospital, MA 02114, USA
    N Engl J Med 358:1240-9. 2008
  4. ncbi Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol
    Navdar Sever
    Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9046, USA
    J Biol Chem 278:52479-90. 2003
  5. ncbi Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase
    Bao Liang Song
    Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Mol Cell 19:829-40. 2005
  6. ncbi Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid
    Mir Hatef Shojaei
    Department of Nutrition and Biochemistry, Tehran University of Medical Sciences, Tehran, Iran
    Iran J Kidney Dis 3:141-4. 2009
  7. ncbi Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction
    JoAnne Micale Foody
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    J Am Geriatr Soc 54:421-30. 2006
  8. ncbi Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene
    Ken Ohashi
    Department of Metabolic Diseases, Faculty of Medicine, University of Tokyo, Tokyo 113 8655, Japan
    J Biol Chem 278:42936-41. 2003
  9. ncbi Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux
    Carmen A Argmann
    Robarts Research Institute, Vascular Biology Group, and the Departments of Medicine and Biochemistry, The University of Western Ontario, London, Ontario N6A 5K8, Canada
    J Biol Chem 280:22212-21. 2005
  10. ncbi Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer
    Steven M Lipkin
    Department of Medicine, Weill Cornell School of Medicine, New York, New York 10021, USA
    Cancer Prev Res (Phila) 3:597-603. 2010

Research Grants

  1. ISOPRENOID BIOSYNTHESIS
    CHARLES POULTER; Fiscal Year: 2002
  2. Sterol Regulation of HMG-CoA Reductase Degradation
    RUSSELL DEBOSE BOYD; Fiscal Year: 2006
  3. 15-LOX-15(S)-HETE axis and angiogenesis
    Gadiparthi N Rao; Fiscal Year: 2010
  4. GENE/DIET EFFECTS ON PLASMA LIPOPROTEIN LEVELS
    Jose Ordovas; Fiscal Year: 2004
  5. Iron Therapy in Renal Disease: Potential Toxicities
    RICHARD ZAGER; Fiscal Year: 2007
  6. ACUTE RENAL FAILURE--MECHANISMS AND ADAPTIVE RESPONSES
    RICHARD ZAGER; Fiscal Year: 2001
  7. ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
    RICHARD ZAGER; Fiscal Year: 2001
  8. Acute Renal Failure: Mechanisms and Adaptive Responses
    RICHARD ZAGER; Fiscal Year: 2007
  9. MECHANISMS IN MYOGLOBINURIC ACUTE RENAL FAILURE
    RICHARD ZAGER; Fiscal Year: 1993
  10. Alternative Splicing in Regulation of Cholesterol Synthesis and Uptake
    Marisa Wong Medina; Fiscal Year: 2010

Detail Information

Publications155 found, 100 shown here

  1. ncbi Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension
    Parshuram J Sonawane
    Cardiovascular Genetics Laboratory, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India
    PLoS ONE 6:e16661. 2011
    3-Hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase gene (Hmgcr) is a susceptibility gene for essential hypertension...
  2. ncbi Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain
    Navdar Sever
    Department of Molecular Genetics, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
    Mol Cell 11:25-33. 2003
    Sterols accelerate degradation of the ER enzyme 3-hydroxy-3-methylglutaryl CoA reductase (HMG CoA reductase), which catalyzes a rate-controlling step in cholesterol biosynthesis...
  3. ncbi Polymorphisms associated with cholesterol and risk of cardiovascular events
    Sekar Kathiresan
    Cardiovascular Disease Prevention Center, Cardiology Division, Massachusetts General Hospital, MA 02114, USA
    N Engl J Med 358:1240-9. 2008
    ..We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease...
  4. ncbi Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol
    Navdar Sever
    Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9046, USA
    J Biol Chem 278:52479-90. 2003
    ....
  5. ncbi Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase
    Bao Liang Song
    Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Mol Cell 19:829-40. 2005
    Sterol-regulated ubiquitination is an obligatory step in ER-associated degradation (ERAD) of HMG CoA reductase, a rate-limiting enzyme in cholesterol synthesis...
  6. ncbi Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid
    Mir Hatef Shojaei
    Department of Nutrition and Biochemistry, Tehran University of Medical Sciences, Tehran, Iran
    Iran J Kidney Dis 3:141-4. 2009
    ..This study was designed to investigate serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who were taking a statin, vitamin B6, and folic acid...
  7. ncbi Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction
    JoAnne Micale Foody
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    J Am Geriatr Soc 54:421-30. 2006
    ..To characterize the relationship between hydroxymethylglutaryl-CoA reductase inhibitors (statins) and outcomes in older persons with acute myocardial infarction (AMI)...
  8. ncbi Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene
    Ken Ohashi
    Department of Metabolic Diseases, Faculty of Medicine, University of Tokyo, Tokyo 113 8655, Japan
    J Biol Chem 278:42936-41. 2003
    ..We used gene targeting to knock out the mouse HMG-CoA reductase gene. The heterozygous mutant mice (Hmgcr+/-) appeared normal in their development and gross anatomy and were fertile...
  9. ncbi Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux
    Carmen A Argmann
    Robarts Research Institute, Vascular Biology Group, and the Departments of Medicine and Biochemistry, The University of Western Ontario, London, Ontario N6A 5K8, Canada
    J Biol Chem 280:22212-21. 2005
    ..Finally, statin treatment inhibited cholesteryl ester accumulation in macrophages challenged with atherogenic hypertriglyceridemic very low density lipoproteins indicating that statins can regulate foam cell formation...
  10. ncbi Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer
    Steven M Lipkin
    Department of Medicine, Weill Cornell School of Medicine, New York, New York 10021, USA
    Cancer Prev Res (Phila) 3:597-603. 2010
    Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR), the rate-limiting enzyme in cholesterol synthesis, modifies the effect of statins on serum cholesterol levels...
  11. ncbi Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression
    Ali C M Johnson
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Am J Pathol 162:283-91. 2003
    ..SR-B1 (a CE influx protein), ABCA1 (a FC exporter), and HMG CoA reductase protein/mRNA levels were also assessed...
  12. ncbi Cholesterol reduction yields clinical benefits: meta-analysis including recent trials
    A Lawrence Gould
    Merck Research Laboratories, West Point, PA 19486, USA
    Clin Ther 29:778-94. 2007
    ..Previous meta-analyses reported by Gould et al found significant decreases of 15% in the risk for coronary heart disease (CHD)-related mortality and 11 % in risk for all-cause mortality per decrease of 10% in total cholesterol (TC) level...
  13. ncbi Lipid lowering for secondary prevention of cardiovascular disease in older adults
    Joseph E Thomas
    Division of Cardiology, University of Kentucky, Lexington, Kentucky, USA
    Drugs Aging 27:959-72. 2010
    ....
  14. ncbi Cancer risk among statin users: a population-based cohort study
    Søren Friis
    Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
    Int J Cancer 114:643-7. 2005
    ..Larger and longer-term studies are needed to determine the potentially protective effect of statin use on cancer development...
  15. ncbi Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells
    Mee Young Hong
    Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    J Nutr Biochem 19:448-58. 2008
    ..was reversed by mevalonate (MV) in LV-treated cells, since LV is a 3-hydroxy-3-methyl-glutaryl CoA reductase (HMGCR) inhibitor. However, RYR with MV did not reverse the observed inhibition of growth...
  16. ncbi Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
    G B John Mancini
    Division of Cardiology, Vancouver Hospital, Jack Bell Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
    J Am Coll Cardiol 47:2554-60. 2006
    The purpose of this study was to determine if statins (hydroxymethylglutaryl CoA reductase inhibitors [HMG-CoA]), angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs) reduce cardiovascular (CV) events ..
  17. ncbi Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis
    Kwang Seok Ahn
    Cytokine Research Section, Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Biol Chem 282:809-20. 2007
    ..Overall, our results demonstrate that gamma-tocotrienol inhibited the NF-kappaB activation pathway, leading to down-regulation of various gene products and potentiation of apoptosis...
  18. ncbi A single nucleotide polymorphism in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene ( HMGCR) influences the serum triacylglycerol relationship with dietary fat and fibre in the European Prospective Investigation into Cancer and Nutrition in Norfo
    Renata N Freitas
    DENCS, School of Nutrition and NUPEB, Federal University of Ouro Preto, Ouro Preto, Brazil
    Br J Nutr 104:765-72. 2010
    ..of the single nucleotide polymorphism (rs17238540) at the 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene (HMGCR) on the relationship between serum lipids and dietary fat and fibre (NSP)...
  19. ncbi Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT)
    Charlotte Manisty
    International Centre for Circulatory Health, Imperial College London and Imperial College Healthcare NHS Trust, London W2 1LA, UK
    Hypertension 54:1009-13. 2009
    ..Atorvastatin treatment is associated with less augmentation of the carotid BP waveform and less wave reflection from the body. This could contribute to the reduction in risk of cardiovascular events by statins...
  20. ncbi Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes
    Dirkje W Sommeijer
    Laboratory for Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, and Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands
    Diabetes Care 27:468-73. 2004
    ..Our objective was to evaluate the effect of pravastatin (40 mg/day) on coagulation and inflammation markers in type 2 diabetic patients...
  21. ncbi Patient-specific prompts in the cholesterol management of renal transplant outpatients: results and analysis of underperformance
    Elizabeth A Garthwaite
    Department of Renal Medicine, St James s University Hospital, Leeds, United Kingdom
    Transplantation 78:1042-7. 2004
    ..It is recommended that "high-risk" patients are treated with hydroxymethylglutaryl CoA reductase inhibitors to reduce cholesterol levels.
  22. ncbi Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades
    C J Carter
    Neurochem Int 52:920-34. 2008
    ..Viral uptake is cholesterol- and lipid raft-dependent (DHCR24, HMGCR, FDPS, RAFTLIN, SREBF1)...
  23. ncbi Synergistic interaction of lovastatin and paclitaxel in human cancer cells
    S A Holstein
    Department of Pharmacology, University of Iowa, Iowa City, Iowa 52242, USA
    Mol Cancer Ther 1:141-9. 2001
    ..These findings provide insight into the mechanisms underlying the cell cycle effects of lovastatin and support the development of a novel therapeutic strategy directed toward altering deleterious cell proliferation...
  24. ncbi Cholesterol biosynthesis from lanosterol. Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein
    S H Bae
    Department of Biochemistry and Bioproducts Research Center, Yonsei University, Seoul, Korea
    J Biol Chem 274:14624-31. 1999
    ..However, the level of hepatic DHCR mRNA fell only slightly, suggesting that AY-9944 may act more rapidly at the protein level than at the level of transcription of the DHCR gene under these conditions...
  25. ncbi Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis
    Mitsuhide Noshiro
    Department of Dental and Medical Biochemistry, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan
    J Biol Rhythms 22:299-311. 2007
    ..and sterol 12alpha-hydroxylase (CYP8B) in bile acid biosynthesis and 3-hydroxyl-3-methylglutaryl CoA reductase (HMGCR) in cholesterol biosynthesis are the key enzymes in hepatic metabolic pathways, and their transcripts exhibit ..
  26. ncbi Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums
    Jeannie Chan
    Southwest National Primate Research Center, Department of Genetics, Southwest Foundation for Biomedical Research, PO Box 760549, San Antonio, TX 78245 0549, USA
    Metabolism 57:718-24. 2008
    ..for (1) 4 bile acid synthesis enzymes (CYP7A1, CYP27A1, CYP8B1, and CYP7B1); (2) 3 cholesterol synthesis enzymes (HMGCR, HMGCS1, and SQLE); (3) the LDL receptor (LDLR); (4) 2 sterol transporters (ABCG5 and ABCG8); and (5) 2 bile acid ..
  27. ncbi Inhibition of the intestinal absorption of bile acids using cationic derivatives: mechanism and repercussions
    Marta Vicens
    Department of Physiology and Pharmacology, Campus Miguel de Unamuno, University of Salamanca, 37007 Salamanca, Spain
    Biochem Pharmacol 73:394-404. 2007
    ..BAPA-3>BAPA-6) reduced the bile acid pool size, which was accompanied by up-regulation of hepatic Cyp7a1 and Hmgcr and intestinal Ostalpha/Ostbeta...
  28. ncbi Dysregulation of the mevalonate pathway promotes transformation
    James W Clendening
    Ontario Cancer Institute, Toronto, ON, Canada
    Proc Natl Acad Sci U S A 107:15051-6. 2010
    ..The mevalonate (MVA) pathway, paced by its rate-limiting enzyme, hydroxymethylglutaryl coenzyme A reductase (HMGCR), is required for the generation of several fundamental end-products including cholesterol and isoprenoids...
  29. ncbi Live imaging of Drosophila gonad formation reveals roles for Six4 in regulating germline and somatic cell migration
    Ivan B N Clark
    Centres for Integrative Physiology and Neuroscience Research, University of Edinburgh, George Square, Edinburgh, UK
    BMC Dev Biol 7:52. 2007
    ..These appear to move in organised groups like, for example, lateral line cells in zebra fish or Drosophila ovarian border cells...
  30. ncbi Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype
    Julio E Celis
    Danish Centre for Translational Breast Cancer Research DCTB, Copenhagen, Denmark
    Mol Cell Proteomics 5:462-83. 2006
    ....
  31. ncbi Activities of natural methyl farnesoids on pupariation and metamorphosis of Drosophila melanogaster
    Grace Jones
    Department of Biology, University of Kentucky, Lexington, KY 40506, United States
    J Insect Physiol 56:1456-64. 2010
    ..If endogenous production of all three larval methyl farnesoids was suppressed by a strongly driven RNAi against HMGCR in the corpora allata cells, most larvae did not attain pupariation...
  32. ncbi Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter
    Richard A Zager
    Department of Medicine, University of Washington, and the Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Kidney Int 63:123-33. 2003
    ..quot; The present study was performed to help define underlying mechanisms, using experimental sepsis as a test model...
  33. ncbi Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro
    Qixuan Chen
    Faculty of Kinesiology and Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
    Nutrition 25:340-9. 2009
    ..The human intestinal cell line, NCI-H716, was used to test the hypothesis that branched-chain amino acids and dairy proteins regulate satiety hormone secretion and modulate genes involved in fatty acid and cholesterol metabolism...
  34. ncbi FSH and FOXO1 regulate genes in the sterol/steroid and lipid biosynthetic pathways in granulosa cells
    Zhilin Liu
    Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA
    Mol Endocrinol 23:649-61. 2009
    ..real time RT-PCR verified, that genes within the lipid, sterol, and steroidogenic biosynthetic pathways (Hmgcs1, Hmgcr, Mvk, Sqle, Lss, Cyp51, Tm7sf2, Dhcr24 and Star, Cyp11a1, and Cyp19), including two key transcriptional regulators ..
  35. ncbi Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells
    M Kobori
    National Food Research Institute, Tsukuba, Ibaraki, Japan
    Br J Pharmacol 150:209-19. 2007
    ..However, its molecular mechanism of action has yet to be determined. Here, we examine the anticancer and anti-inflammatory effects of ergosterol peroxide...
  36. ncbi A novel statin-mediated "prenylation block-and-release" assay provides insight into the membrane targeting mechanisms of small GTPases
    Bassam R Ali
    Department of Pathology, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
    Biochem Biophys Res Commun 397:34-41. 2010
    ..Here we used the HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase (HMGCR) inhibitor mevastatin to develop a 'prenylation block-and-release' assay that allows membrane targeting of ..
  37. ncbi Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase
    K I Mitchelhill
    St Vincent s Institute of Medical Research, Fitzroy, Victoria, Australia
    J Biol Chem 269:2361-4. 1994
    ....
  38. ncbi The AMP-activated protein kinase--fuel gauge of the mammalian cell?
    D G Hardie
    Biochemistry Department, The University, Dundee, UK
    Eur J Biochem 246:259-73. 1997
    ..AMPK/SNF1 homologues are found in higher plants, and this protein-kinase cascade appears to be an ancient system which evolved to protect cells against the effects of nutritional or environmental stress...
  39. ncbi Chemorefractory rhabdomyosarcoma treated with radiotherapy, bevacizumab, statins and surgery and maintenance with bevacizumab and chemotherapy
    Ola Linden
    Department of Oncology, Lund University Hospital, Sweden
    Onkologie 31:391-3. 2008
    ..Rhabdomyosarcoma is a rare disease in children and young adults, usually responsive to chemotherapy. Here we report on a patient with chemorefractory disease, treated in an unconventional approach...
  40. ncbi A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia
    Brian W McCrindle
    Department of Pediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Canada
    Pediatr Res 51:715-21. 2002
    ..to determine whether a low-dose combination of a bile acid-binding resin (colestipol) with an hydroxymethylglutaryl CoA reductase inhibitor (pravastatin) would result in improved acceptability, compliance, and effectiveness in ..
  41. ncbi Regulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells
    Murugesan Palaniappan
    Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    Biol Reprod 81:284-92. 2009
    ..an increase in the expression of selected SREBF target genes, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (Hmgcr) and mevalonate kinase (Mvk), was also observed...
  42. ncbi Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands
    Chendong Yang
    Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, 75390, USA
    J Biol Chem 281:27816-26. 2006
    ..These observations are consistent with specific intermediates in the cholesterol biosynthetic pathway regulating lipid homeostasis through both the LXR and sterol response element-binding protein pathways...
  43. ncbi Perspectives of the non-statin hypolipidemic agents
    Damjana Rozman
    Center for Functional Genomics and Bio Chips, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
    Pharmacol Ther 127:19-40. 2010
    ..In addition to 3beta-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), as the major regulatory enzyme of cholesterol synthesis that is the target of statins, some other enzymes of ..
  44. ncbi Impact of nandrolone decanoate on gene expression in endocrine systems related to the adverse effects of anabolic androgenic steroids
    Johan Alsiö
    Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Uppsala, Sweden
    Basic Clin Pharmacol Toxicol 105:307-14. 2009
    ..The results provide evidence for wide ranging effects of AAS on the hypothalamic-pituitary-adrenal axis, adipose tissue and substrates of the renal control of blood pressure...
  45. ncbi Simvastatin treatment in the SLO syndrome: a safe approach?
    Lena Starck
    Sachs Children s Hospital, Department of Paediatrics, Karolinska Institute, Stockholm, Sweden
    Am J Med Genet 113:183-9. 2002
    ..In order to see whether inhibition of hydroxymethylglutaryl CoA reductase is of benefit, two of our patients have been treated with simvastatin in addition to the long-term ..
  46. ncbi Production of geranylgeraniol on overexpression of a prenyl diphosphate synthase fusion gene in Saccharomyces cerevisiae
    Chikara Ohto
    Bio Research Lab, Toyota Motor Corporation, 1 Toyota cho, Toyota 471 8572, Japan
    Appl Microbiol Biotechnol 87:1327-34. 2010
    ..The GGOH content on the diploid cultivation in a 5-l jar fermenter reached 138.8 mg/l under optimal conditions...
  47. ncbi Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?
    Hong Li
    Department of Medicine, State University of New York, Stony Brook, NY 11794 8152, USA
    Circulation 105:1037-43. 2002
    ..It has been established that hyperhomocyst(e)inemia (HHCy) is an independent and graded risk factor for atherosclerosis, although the molecular link to the atherosclerotic process remains obscure...
  48. ncbi Dietary phytosterols and phytostanols alter the expression of sterol-regulatory genes in SHRSP and WKY inbred rats
    Qixuan Chen
    Nutrition Research Division, Food Directorate, Health Products and Food Branch, Health Canada, Banting Research Centre, 251 Sir Frederick Banting Driveway, Ottawa, Ontario, Canada
    Ann Nutr Metab 55:341-50. 2009
    ....
  49. ncbi Sequential effects of a high-fiber diet with psyllium husks on the expression levels of hepatic genes and plasma lipids
    Mei Yen Chan
    Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    Nutrition 24:57-66. 2008
    ..We studied the sequential effects of a high-fiber diet using psyllium husks on hepatic gene expression and plasma lipid levels...
  50. ncbi Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model
    Liliane Meunier
    Centre de Recherche du Centre Hospitalier de l Université de Montréal Institut du cancer de Montréal, Montreal, Quebec, Canada
    Transl Oncol 3:230-8. 2010
    ..Ten genes (IRS2, CTSD, NRAS, MLXIP, HMGCR, LAMP1, ETS2, NID1, SMARCD1, and CD44) were upregulated in OV-90 cells exposed to ascites, allowing a ..
  51. ncbi Effect of hydroxymethylglutaryl-CoA reductase inhibitors on low-density lipoprotein cholesterol, interleukin-6, and high-sensitivity C-reactive protein in end-stage renal disease
    Alireza Soliemani
    Department of Internal Medicine, Kashan University of Medical Sciences, Iran
    Iran J Kidney Dis 5:29-33. 2011
    ..Atorvastatin was much more effective than lovastatin, while CRP reduction was not significant by simvastatin. However, simvastatin had the greatest impact on LDLC. None of these drugs could reduce IL-6 levels within 2 months...
  52. ncbi Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip
    Philippa J Talmud
    Centre for Cardiovascular Genetics, Department of Medicine, University College London, London WC1E 6JF, UK
    Am J Hum Genet 85:628-42. 2009
    ..SNPs associated with LDL cholesterol and apolipoprotein B were located in LDLR, PCSK9, APOB, CELSR2, HMGCR, CETP, the TOMM40-APOE-C1-C2-C4 cluster, and the APOA5-A4-C3-A1 cluster; SNPs associated with HDL cholesterol and ..
  53. ncbi Regulation of intracellular cholesterol distribution by Na/K-ATPase
    Yiliang Chen
    Department of Physiology and Pharmacology, College of Medicine, University of Toledo, Toledo, Ohio 43614 2598, USA
    J Biol Chem 284:14881-90. 2009
    ..Moreover, the data also suggest that the plasma membrane Na/K-ATPase-caveolin-1 interaction may represent an important sensing mechanism by which the cells regulate the sterol regulatory element-binding protein pathway...
  54. ncbi HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury
    Ali Cm Johnson
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Clin J Am Soc Nephrol 6:2108-13. 2011
    Experimental acute kidney injury (AKI) activates the HMG-CoA reductase (HMGCR) gene, producing proximal tubule cholesterol loading. AKI also causes sloughing of proximal tubular cell debris into tubular lumina...
  55. ncbi Sequential responses to high-fat and high-calorie feeding in an obese mouse model
    Mei Yen Chan
    Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
    Obesity (Silver Spring) 16:972-8. 2008
    ..Reports on the immediate and long-term responses to high-fat and high-calorie (HFC) feeding are controversial. Therefore, we examined the sequential effects of an HFC diet...
  56. ncbi Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice
    Katrin Martens
    Laboratory of Cell Metabolism, Department of Pharmaceutical Sciences, K U Leuven, Leuven, Belgium
    Biochim Biophys Acta 1781:694-702. 2008
    ..Real-time PCR confirmed the induction of PPAR alpha target genes and of HMGCR and SREBP2, both involved in cholesterol synthesis, in lactating and in adult MFP2 knockout mice...
  57. ncbi Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment
    Ronald M Krauss
    Children s Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609, USA
    Circulation 117:1537-44. 2008
    Use of 3-hydroxyl-3-methylglutaryl-3 coenzyme A reductase (HMGCR) inhibitors, or statins, reduces cardiovascular disease risk by lowering plasma low-density lipoprotein cholesterol (LDL-C) concentrations...
  58. ncbi Implications of discoveries from genome-wide association studies in current cardiovascular practice
    Panniyammakal Jeemon
    Panniyammakal Jeemon, Kerry Pettigrew, Christopher Sainsbury, Sandosh Padmanabhan, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, G12 8TA, United Kingdom
    World J Cardiol 3:230-47. 2011
    ..MTHFD1L, CELSR2, PSRC1 and SORT1 genes have been associated with CHD, and TMEM57, DOCK7, CELSR2, APOB, ABCG5, HMGCR, TRIB1, FADS2/S3, LDLR, NCAN and TOMM40-APOE with total cholesterol...
  59. ncbi Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene
    Masayo Naito
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Am J Pathol 174:54-62. 2009
    ..However, the factors during acute kidney injury that regulate HMG CoA reductase (HMGCR) activity, the rate-limiting step in cholesterol synthesis, have not been defined...
  60. ncbi A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study
    Louise A Donnelly
    Division of Community Health Sciences, University of Dundee, Mackenzie Building, Kirsty Semple Way, Dundee, UK
    Pharmacogenet Genomics 18:1021-6. 2008
    ..variation exists in cholesterol-lowering response to 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors (statins)...
  61. ncbi Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: a spectrum of the same disease process
    Peter A McCullough
    Department of Medicine, Divisions of Cardiology, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Adv Chronic Kidney Dis 15:396-412. 2008
    ....
  62. ncbi Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase
    DANIEL J CONKLIN
    Diabetes and Obesity Center, University of Louisville, Louisville, KY 40292, USA
    Mol Nutr Food Res 55:1411-22. 2011
    ..Because lipid synthesis and trafficking are largely under hepatic control, we examined hepatic genes in murine models of acute and chronic oral acrolein exposure...
  63. ncbi Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis
    Jayoung Choi
    Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA 90095, USA
    Development 138:1173-81. 2011
    ..indicate that aplexone differentially regulates arteriovenous angiogenesis by targeting the HMG-CoA reductase (HMGCR) pathway...
  64. ncbi Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatment
    Peter O Kwiterovich
    Division of Lipid Research Atherosclerosis, Johns Hopkins Medical Institutions, 550 North Broadway, Suite 310, Baltimore, MD 21205, USA
    J Clin Lipidol 2:248-66. 2008
    ..Optimal detection and treatment of high-risk children either from the general population or from families with premature CVD will require a comprehensive universal screening and evaluation program...
  65. ncbi Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease
    Jeffrey L Anderson
    Cardiovascular Department, Intermountain Medical Center, Murray, UT 84107, USA
    Am Heart J 160:250-256.e3. 2010
    ....
  66. ncbi The role of HMGCR alternative splicing in statin efficacy
    Marisa Wong Medina
    Children s Hospital Oakland Research Institute, CA 94609, USA
    Trends Cardiovasc Med 19:173-7. 2009
    Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, are widely prescribed to lower plasma cholesterol levels and reduce cardiovascular disease risk...
  67. ncbi Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins
    Kuo Liong Chien
    Institute of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
    Pharmacogenomics 11:309-17. 2010
    ..This study assessed the association between pharmacokinetic- and pharmacodynamic-related genes and individual responses to low-density lipoprotein cholesterol (LDL-C) change by statins in a Chinese population...
  68. ncbi Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy
    E Benedetti
    Department of Basic and Applied Biology, University of LAquila, Italy
    Int J Immunopathol Pharmacol 23:235-46. 2010
    ....
  69. ncbi Gene-gene and gene - clinical factors interaction in acute myocardial infarction: a new detailed risk chart
    F Licastro
    Department of Experimental Pathology, School of Medicine, University of Bologna, Italy
    Curr Pharm Des 16:783-8. 2010
    ..and interferon gamma (IFN)-gamma genes along with SNPs of genes regulating vascular functions (vascular endothelial growth factor; VEGF) and cholesterol synthesis (hydroxy-methyl-glutaryl CoA reductase; HMGCR) were investigated.
  70. ncbi A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protei
    Limin Tian
    Endocrinology, Provincial Hospital affiliated to Shandong University, Jinan, China
    Hepatology 52:1401-9. 2010
    ..demonstrated that in liver cells, TSH promoted the expression of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase (HMGCR), a rate-limiting enzyme in cholesterol synthesis, by acting on the TSH receptor in hepatocyte membranes and ..
  71. ncbi Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy
    Aruna Poduri
    Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research PGIMER, Chandigarh, India
    DNA Cell Biol 29:629-37. 2010
    ..We studied the association between 18 single-nucleotide polymorphisms (SNPs) in six genes (HMGCR, CETP, APOAI, ABCB1, CYP3A4, CYP7A1) in response to atorvastatin therapy (20?mg/day) in 265 newly diagnosed CAD ..
  72. ncbi Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance
    Mitsuru Shinohara
    Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Suita, Osaka 565 0871, Japan
    J Biol Chem 285:22091-102. 2010
    ..These results have important implications for the development of disease-modifying therapy for Alzheimer disease as well as understanding of Abeta metabolism...
  73. ncbi A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations
    Lina Keller
    Department NVS, KI Alzheimer Disease Research Center, Karolinska Institutet, Huddinge, SE 14157 Stockholm, Sweden
    Brain Res 1344:185-91. 2010
    ..investigated the influence of the -911C>A polymorphism (rs3761740) in the hydroxy-methyl-glutaryl CoA reductase (HMGCR) gene promoter on basal and regulated transcription, plasma cholesterol levels and the association with AD...
  74. ncbi Improvement of dyslipidemia in OLETF rats by the prostaglandin I(2) analog beraprost sodium
    Maho Watanabe
    Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, 7 45 1 Nanakuma, Jonann ku, Fukuoka 814 0180, Japan
    Prostaglandins Other Lipid Mediat 93:14-9. 2010
    ..sacrifice, using the quantitative real-time PCR, we assayed the transcription levels of the HMG-CoA reductase (Hmgcr) for cholesterol biosynthesis, monoacylglycerol O-acyltransferase 1 (Mogat1) as TG synthetase, hepatic ..
  75. ncbi Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis
    I Campia
    Department of Genetics, Biology and Biochemistry, University of Torino, Via Santena, Torino, Italy
    Br J Pharmacol 158:1777-86. 2009
    ..As a consequence, statins impair mitochondrial metabolism and the activation of small monomeric GTPases (such as Rho and Ras), causing toxic effects. To date, a successful strategy to prevent statin toxicity is lacking...
  76. ncbi Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program
    Ulrika Andersson
    Division of Diabetes, Metabolism and Endocrinology, Department of Experimental Medical Sciences, Lund University, Lund, Sweden
    Am J Physiol Endocrinol Metab 300:E111-21. 2011
    ....
  77. ncbi [Adverse drug reactions of hydroxymethylglutaryl-CoA reductase inhibitors reported to agency for medicinal products and medical devices]
    Nikica Mirosević Skvrce
    Agencija za lijekove i medicinske proizvode, Zagreb
    Lijec Vjesn 132:277-82. 2010
    ..003). Most serious ADRs could have been prevented with better understanding of interactions and by use of pharmacogenomics in identifying patients that are because of genetic predisposition more sensitive to standard doses...
  78. ncbi [Oxidized low-density lipoprotein enhances the expressions of SREBP-2 and HMGCR mRNA in macrophages derived from the monocytes of patients with acute coronary syndrome]
    Pei dong Zhang
    Department of Cardiovascular Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
    Nan Fang Yi Ke Da Xue Xue Bao 29:929-32. 2009
    ..lipoprotein (ox-LDL) on the expressions of sterol regulatory element binding protein-2 (SREBP-2) and hydroxymethylglutaryl CoA reductase (HMGCR) in the macrophages derived from monocytes of patients with acute coronary syndrome (ACS).
  79. ncbi A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians
    Aruna Poduri
    Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research PGIMER, Chandigarh, India
    DNA Cell Biol 28:451-60. 2009
    ..Fifteen SNPs of CETP, ABCB1, APOAI, CYP7A1, and HMGCR genes were genotyped in 265 CAD patients and 150 controls of North Indian origin...
  80. ncbi Defects in cholesterol synthesis genes in mouse and in humans: lessons for drug development and safer treatments
    Simon Horvat
    Department of Animal Science, University of Ljubljana, Domzale, Slovenia
    Drug Metab Rev 43:69-90. 2011
    ..with loss of function of early cholesterogenic enzymes have not yet been described, and in the mouse, loss of Hmgcr is preimplantation lethal...
  81. ncbi Suppressed production of methyl farnesoid hormones yields developmental defects and lethality in Drosophila larvae
    Davy Jones
    Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40506, USA
    Gen Comp Endocrinol 165:244-54. 2010
    ..In this study, we have used RNAi techniques to inhibit 3-Hydroxy-3-Methylglutaryl CoA Reductase (HMGCR) expression selectively in the corpora allatal cells that produce the circulating farnesoid hormones...
  82. ncbi Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism
    Paul W Caton
    Department of Translational Medicine and Therapeutics, Bart s and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, UK
    J Endocrinol 208:273-83. 2011
    ..In addition, levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase (Hmgcr) and acetyl-coA carboxylase (Acc) mRNA, and intracellular cholesterol were increased...
  83. ncbi Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice
    Constance Schmelzer
    Institute of Human Nutrition and Food Science, Molecular Prevention, Christian Albrechts University of Kiel, Heinrich Hecht Platz 10, Kiel, Germany
    Mol Nutr Food Res 54:805-15. 2010
    ..g. HMGCS1, HMGCL and HMGCR), fat assimilation (FABP5), lipoprotein metabolism (PLTP) and inflammation (STAT-1)...
  84. ncbi Differential metabolic effects of distinct statins
    Kwang Kon Koh
    Vascular Medicine and Atherosclerosis Unit, Cardiology, Gachon University, Gil Medical Center, 1198 Kuwol dong, Namdong gu, Incheon 405 760, Republic of Korea
    Atherosclerosis 215:1-8. 2011
    ..In this review, we discuss these differential effects of statins on metabolic homeostasis and insulin sensitivity...
  85. ncbi Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases
    M Zaiou
    Unité de recherche Génétique Cardiovasculaire, Nancy Universite, Faculte de Pharmacie, 30, rue Lionnois, 54000 Nancy, France
    Curr Pharm Des 15:3193-206. 2009
    ..shown that genetic variations within cytochromes P450 (CYPs), 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase (HMGCR) and apolipoprotein E (APOE) genes influence individual's response to lipid lowering statins...
  86. ncbi A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women
    Viktor Hamrefors
    Department of Clinical Sciences, Lund University, Malmo, Sweden
    J Lipid Res 51:625-34. 2010
    ..the right carotid artery, thus candidates for statin therapy, we related score LDL [APOB(rs693), APOE(rs4420638), HMGCR(rs12654264), LDLR(rs1529729), and PCSK9(rs11591147)] and score HDL [ABCA1(rs3890182), CETP(rs1800775), LIPC(..
  87. ncbi Tetra-glutamic acid residues adjacent to Lys248 in HMG-CoA reductase are critical for the ubiquitination mediated by gp78 and UBE2G2
    Honghua Miao
    The State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
    Acta Biochim Biophys Sin (Shanghai) 42:303-10. 2010
    Sterol-regulated degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is a rapid feedback regulatory mechanism by which cells employ to control the cholesterol biosynthesis...
  88. ncbi [Association of HMG-CoA reductase gene polymorphism with levels of lipids]
    Yu Tong
    Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20:207-10. 2003
    ..To study the distribution of ScrF1 restriction polymorphism in intron 2 of the 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase gene in Chinese Han population and the association of the polymorphism with coronary heart disease(CHD)...
  89. ncbi Statins reduce amyloid-beta production through inhibition of protein isoprenylation
    Stephen M Ostrowski
    Department of Neurosciences, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA
    J Biol Chem 282:26832-44. 2007
    ..These studies provide insight into the mechanisms by which statins may reduce AD pathogenesis...
  90. ncbi Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells
    Francesco Natali
    Laboratory of Biochemistry and Molecular Biology, Department of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy
    J Lipid Res 48:1966-75. 2007
    ..Oleic acid also reduced the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR)...
  91. ncbi HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection
    Joannis E Vamvakopoulos
    Department of Surgery, University of Cambridge, Cambridge, UK
    BMC Cardiovasc Disord 3:6. 2003
    ..Since macrophages participate in several vascular pathologies, we examined the effect of statin treatment on the survival and differentiation of primary human monocytes...
  92. ncbi Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene
    H Rosen
    Department of Molecular Virology, Faculty of Medicine, Hebrew University, 91120 Jerusalem, Israel
    J Biol Chem 273:14805-12. 1998
    ..The results do not support the contention that 27-hydroxylated steroids are critical for maintenance of cholesterol homeostasis or levels of vitamin D metabolites in the circulation...
  93. ncbi HMG-CoA reductase guides migrating primordial germ cells
    M Van Doren
    Skirball Institute, Department of Cell Biology, New York University Medical Center, New York 10016, USA
    Nature 396:466-9. 1998
    ..We conclude that the regulated expression of HMG-CoA reductase has a critical developmental function in providing spatial information to guide migrating primordial germ cells...
  94. ncbi CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver
    Jure Acimovic
    Centre for Functional Genomics and Bio Chips, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, Ljubljana, Slovenia
    Biochem Biophys Res Commun 376:206-10. 2008
    ..Cyp51, Fpps, and Sqs lost the circadian behavior in Crem-/- livers while Hmgcr is phase advanced from CT20 to CT12...
  95. ncbi Molecular markers for animal biotechnology: sea bass (Dicentrarchus labrax, L.) HMG-CoA reductase mRNA
    Rosalba Gornati
    Dipartimento di Biotecnologie e Scienze Molecolari, Universita dell Insubria, 3 Via Dunant, I 21100 Varese, Italy
    Gene 344:299-305. 2005
    ..available in the public data bases, resulted to be the 3-hydroxil-3-methyl-glutaryl coenzyme A reductase (HMGCR)...
  96. ncbi Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase gene expression by CuZn superoxide dismutase in human fibroblasts and HepG2 cells
    Bruna De Felice
    Department of Life Sciences, University of Naples 2, Via Vivaldi, 43, Caserta, Italy
    Gene Expr 12:29-38. 2004
    ..Accordingly, SOD1 could be used as a potential agent in the treatment of hypercholesterolemia, even in subjects lacking a functional LDL receptor pathway...
  97. ncbi Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors
    B A Duplaga
    College of Pharmacy, The University of Illinois at Chicago 60612, USA
    Ann Pharmacother 33:1224-7. 1999
    ....
  98. ncbi A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters
    B Hsiang
    Bristol Myers Squibb Co, Pharmaceutical Research Institute, Princeton, New Jersey 08543 4000, USA
    J Biol Chem 274:37161-8. 1999
    ..Furthermore, the identification of oatp1 and OATP2 as pravastatin transporters suggests that they are responsible for the hepatic uptake of this liver-specific hydroxymethylglutaryl-CoA reductase inhibitor in rat and man...
  99. ncbi Copper induces the expression of cholesterogenic genes in human macrophages
    Per Arne Svensson
    Department of Internal Medicine, Research Centre for Endocrinology and Metabolism RCEM, Vita straket 12, Sahlgrenska Academy, Goteborg University, S 41345 Gothenburg, Sweden
    Atherosclerosis 169:71-6. 2003
    ..The expression of LDL-R and HMG CoA reductase was also investigated using real time PCR...
  100. ncbi The mevalonate pathway during acute tubular injury: selected determinants and consequences
    Richard A Zager
    Department of Medicine, The University of Washington, and the Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Pathol 161:681-92. 2002
    Renal injury evokes tubular cholesterol accumulation, mediated in part by increased HMG CoA reductase (HMGCR) levels...
  101. ncbi Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase
    Jian Cao
    State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China
    Cell Metab 6:115-28. 2007
    ..In summary, our study identifies Ufd1 as a cofactor of gp78, reveals an unappreciated function of Ufd1 in the ubiquitination reaction during ERAD, and illustrates that Ufd1 plays a critical role in cholesterol metabolism...

Research Grants67

  1. ISOPRENOID BIOSYNTHESIS
    CHARLES POULTER; Fiscal Year: 2002
    ....
  2. Sterol Regulation of HMG-CoA Reductase Degradation
    RUSSELL DEBOSE BOYD; Fiscal Year: 2006
    ..Excess sterols accelerate degradation of HMG-CoA reductase (HMGCR), a major focal point in the regulation isoprenoid biosynthesis in animal cells...
  3. 15-LOX-15(S)-HETE axis and angiogenesis
    Gadiparthi N Rao; Fiscal Year: 2010
    ..formation and aortic ring and Matrigel plug angiogenesis require 3-hydroxy-3-methyl glutaryl coenzyme-A reductase (HMGCR) activity...
  4. GENE/DIET EFFECTS ON PLASMA LIPOPROTEIN LEVELS
    Jose Ordovas; Fiscal Year: 2004
    ..Proteins (SREBP1 and SREBP2), SREBP cleavage-activating protein (SCAP), 3- Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR), Scavenger Receptor Class B-I (SRBI), Intestinal Fatty Acid-Binding Protein (FABP2), and ATP-Binding Cassette 1 (..
  5. Iron Therapy in Renal Disease: Potential Toxicities
    RICHARD ZAGER; Fiscal Year: 2007
    ..cell, and plasma, cholesterol concentrations, and arises in part from an Fe-induced upregulation of HMG CoA reductase levels and activity...
  6. ACUTE RENAL FAILURE--MECHANISMS AND ADAPTIVE RESPONSES
    RICHARD ZAGER; Fiscal Year: 2001
    ....
  7. ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
    RICHARD ZAGER; Fiscal Year: 2001
    ....
  8. Acute Renal Failure: Mechanisms and Adaptive Responses
    RICHARD ZAGER; Fiscal Year: 2007
    ....
  9. MECHANISMS IN MYOGLOBINURIC ACUTE RENAL FAILURE
    RICHARD ZAGER; Fiscal Year: 1993
    ..By addressing the above, new insights into heme protein/low molecular weight protein nephrotoxicity and shock-induced renal damage will be obtained which should have direct relevance to crush syndrome induced ARF...
  10. Alternative Splicing in Regulation of Cholesterol Synthesis and Uptake
    Marisa Wong Medina; Fiscal Year: 2010
    ..the two most critical regulators of intracellular cholesterol, 3-hydroxy-3-methylglutaryl- coenzyme A reductase (HMGCR), the rate-limiting enzyme of cholesterol biosynthesis, and the LDL receptor (LDLR), responsible for uptake of LDL,..
  11. DISPOSITION AND MOVEMENT OF CHOLESTEROL IN CELLS
    Yvonne Lange; Fiscal Year: 1993
    ..These studies should increase our understanding of the disposition of cellular cholesterol, its incorporation into ester droplets, and, hopefully, the basis of atherosclerosis...
  12. Cellular Cholesterol Movement and Homeostasis
    Yvonne Lange; Fiscal Year: 2009
    ..Elucidating the physiology and practical implications of membrane cholesterol complexes and cholesterol activity will hopefully play a role in the development of therapeutic and preventive approaches to cholesterol-related diseases. . ..
  13. Cellular Cholesterol Movement and Homeostasis
    Yvonne Lange; Fiscal Year: 2010
    ..Elucidating the physiology and practical implications of membrane cholesterol complexes and cholesterol activity will hopefully play a role in the development of therapeutic and preventive approaches to cholesterol-related diseases. . ..
  14. CELLULAR CHOLESTEROL MOVEMENT AND HOMEOSTATSIS
    Yvonne Lange; Fiscal Year: 2002
    ..Finally, the cell physiology of several sequenced mutants in NPC1 will be analyzed with respect to the gene defect to examine how NPC1 might function in cholesterol homeostasis. ..
  15. Cellular Cholesterol Movement and Homeostasis
    Yvonne Lange; Fiscal Year: 2007
    ..abstract_text> ..
  16. COMPARATIVE GENOMIC ANALYSIS OF CARDIOVASCULAR GENE REGU
    Ronald Krauss; Fiscal Year: 2003
    ..6) The establishment of an educational program for cardiovascular researchers in the use of genomic databases and tools. ..
  17. Pharmacogenomics and Risk of Cardiovascular Disease
    Ronald Krauss; Fiscal Year: 2007
    ..This program presents a comprehensive approach for determining effects of specific genotypes on clinically meaningful variations in responsiveness to a class of drugs widely used to prevent cardiovascular disease. ..
  18. Osteoprotegerin Pathway: Relations of Genes & Biomarkers to CVD in the Community
    Sekar Kathiresan; Fiscal Year: 2007
    ..In addition, the candidate will be well positioned to transition from conducting pathway-based investigation to genome-wide association studies for cardiovascular phenotypes. ..